Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0

NCT02756013 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual - terminated

Conditions

Gynecologic Malignancies

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Case Comprehensive Cancer Center